Ponatinib and Vitrakvi (Larotrectinib Oral Solution)
Determining the interaction of Ponatinib and Vitrakvi (Larotrectinib Oral Solution) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Based on in vitro inhibition data, coadministration with ponatinib may increase the plasma concentrations of drugs that are substrates of the P-glycoprotein (P-gp) transporter. The proposed mechanism is decreased clearance in the intestine, liver, and/or kidney due to inhibition of P-glycoprotein-mediated drug efflux by ponatinib. MANAGEMENT: Caution is advised when ponatinib is used concurrently with drugs that are known P-gp substrates, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever ponatinib is added to or withdrawn from therapy. References "Product Information. Iclusig (ponatinib)." Ariad Pharmaceuticals Inc, Cambridge, MA.
Professional:MONITOR: Based on in vitro inhibition data, coadministration with ponatinib may increase the plasma concentrations of drugs that are substrates of the P-glycoprotein (P-gp) transporter. The proposed mechanism is decreased clearance in the intestine, liver, and/or kidney due to inhibition of P-glycoprotein-mediated drug efflux by ponatinib.
MANAGEMENT: Caution is advised when ponatinib is used concurrently with drugs that are known P-gp substrates, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever ponatinib is added to or withdrawn from therapy.
- "Product Information. Iclusig (ponatinib)." Ariad Pharmaceuticals Inc, Cambridge, MA.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Vitrakvi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ponatinib-Vitrase
- Ponatinib-Vitrase injection
- Ponatinib-Vitravene
- Ponatinib-Vitron-C
- Ponatinib-Vituz
- Ponatinib-Vituz Oral Solution
- Vitrakvi (Larotrectinib Oral Solution)-Ponstel
- Vitrakvi (Larotrectinib Oral Solution)-Pontocaine
- Vitrakvi (Larotrectinib Oral Solution)-Pontocaine HCl
- Vitrakvi (Larotrectinib Oral Solution)-Porfimer
- Vitrakvi (Larotrectinib Oral Solution)-Porfimer Intravenous
- Vitrakvi (Larotrectinib Oral Solution)-Portia